Table 1:
Study | Country | N | Year | Age Range | Personality Scale | Follow-up (Years) | N (% Dead) |
---|---|---|---|---|---|---|---|
EAS | U.S. | 474.00 | 2,005.00 | 69–94 | IPIP-50 | 11.08 | 128 (22.30) |
HRS | U.S. | 19,211.00 | 2,006.00 | 25–105 | MIDI | 9.13 | 3,066 (15.96) |
LBC1936 | U.K. | 962.00 | 2,006.00 | 67–71 | IPIP | 14.23 | 218 (22.66) |
LBLS | U.S. | 898.00 | 1,994.00 | 30–97 | NEO-PI-R | 19.00 | 131 (14.59) |
MAP | U.S. | 653.00 | 2,004.00 | 56–97 | NEO-FFI | 13.89 | 268 (41.04) |
MAS | Australia | 879.00 | 2,005.00 | 70–91 | NEO-PI-R | 8.42 | 180 (20.48) |
MIDUS | U.S. | 6,245.00 | 1,994.00 | 20–75 | MIDI | 21.12 | 1,069 (17.12) |
NAS | U.S. | 992.00 | 1,990.00 | 47–85 | Goldberg | 26.90 | 659 (66.43) |
OATS | Australia | 534.00 | 2,007.00 | 65–90 | NEO-PI-R | 9.57 | 56 (10.49) |
ROS | U.S. | 1,394.00 | 1,994.00 | 55–102 | NEO-FFI | 24.00 | 792 (56.81) |
SLS | U.S. | 1,649.00 | 2,001.00 | 26–101 | NEO-PI-R | 16.19 | 444 (26.93) |
WLS | U.S. | 10,711.00 | 1,993.00 | 33–75 | BFI | 22.33 | 1,777 (16.59) |